Apellis Pharmaceuticals, Inc. (APLS)

25.16 +0.34 (+1.37%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Apellis Pharmaceuticals Average Diluted Shares Outstanding (Annual)

Average Diluted Shares Outstanding (Annual) Chart

View Average Diluted Shares Outstanding (Annual) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Annual) Range, Past 5 Years

View Average Diluted Shares Outstanding (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Annual) Benchmarks

View Average Diluted Shares Outstanding (Annual) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade